The Generic Anti-Retroviral Procurement Project and the Treatment Action Campaign (TAC) Treatment Project asked multinational pharmaceutical company Boehringer Ingelheim this week for permission to import generic nevirapine for use in combination antiretroviral therapy, failing which they will seek compulsory licenses in court.